Table 1 Patient and operation details (op.time: operation time, postop.: postoperative, *Endo close (United States Surgical Corporation, division of Tyco Healthcare Group LP) utilized to obtain port site hemostasis

1

210

3

120

Endo close*

2

360

2

175

Endo close*, transfusion

3

105

1

104

4

135

1

127

7-cm cervix

5

155

2

120

6

165

4

130

275 g

Endo close*, bladder perforation

7

230

2

130

Transfusion (×6 previous laparotomies)

8

140

3

103

9

135

1

106

10

150

2

100

11

105

3

111

12

135

1

117

255 g

Endometriosis obliterating Pouch of Douglas

13

150

1

140

295 g

14

155

3

106

265 g

15

240

12

105

Laparovaginal repair with SPC for 12 days

16

125

2

130

17

220

2

105

450 g

Cervical fibroid (postop. Hb 82)

18

225

2

127

255 g

19

260

2

107

780 g

Morcellation of uterus

20

160

2

102

Endometrial cancer

21

135

1

102

22

140

2

100

23

135

2

115

Endo close*

24

255

3

125

275 g

Transfusion; vault Pseudomonas infection

25

195

2

120

26

160

3

100

255 g

Vault infection

27

135

1

124